GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LBX Pharmacy Chain JSC (SHSE:603883) » Definitions » Debt-to-EBITDA

LBX Pharmacy Chain JSC (SHSE:603883) Debt-to-EBITDA

: 4.85 (As of Sep. 2023)
View and export this data going back to 2015. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

LBX Pharmacy Chain JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ¥2,288 Mil. LBX Pharmacy Chain JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ¥3,445 Mil. LBX Pharmacy Chain JSC's annualized EBITDA for the quarter that ended in Sep. 2023 was ¥1,183 Mil. LBX Pharmacy Chain JSC's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 4.85.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for LBX Pharmacy Chain JSC's Debt-to-EBITDA or its related term are showing as below:

SHSE:603883' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.26   Med: 2.04   Max: 4.2
Current: 3.57

During the past 12 years, the highest Debt-to-EBITDA Ratio of LBX Pharmacy Chain JSC was 4.20. The lowest was 0.26. And the median was 2.04.

SHSE:603883's Debt-to-EBITDA is ranked worse than
61.87% of 417 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs SHSE:603883: 3.57

LBX Pharmacy Chain JSC Debt-to-EBITDA Historical Data

The historical data trend for LBX Pharmacy Chain JSC's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBX Pharmacy Chain JSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.26 2.00 4.20 2.68 2.08

LBX Pharmacy Chain JSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.89 3.00 2.94 3.44 4.85

Competitive Comparison

For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBX Pharmacy Chain JSC Debt-to-EBITDA Distribution

For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where LBX Pharmacy Chain JSC's Debt-to-EBITDA falls into.



LBX Pharmacy Chain JSC Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

LBX Pharmacy Chain JSC's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2056.345 + 3399.514) / 2625.373
=2.08

LBX Pharmacy Chain JSC's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2287.752 + 3445.284) / 1183.256
=4.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.


LBX Pharmacy Chain JSC  (SHSE:603883) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


LBX Pharmacy Chain JSC Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of LBX Pharmacy Chain JSC's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


LBX Pharmacy Chain JSC (SHSE:603883) Business Description

Traded in Other Exchanges
N/A
Address
No. 288, Xiangya Road, Kaifu District, Hunan, Changsha, CHN, 410005
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.

LBX Pharmacy Chain JSC (SHSE:603883) Headlines

No Headlines